Morphological studies of the distribution of insulin receptors on rat adipocyte plasma membranes using monomeric ferritininsulin have shown that the occupied insulin receptors occurred predominantly in natural groups of two to six receptors (1, 2) . In contrast, the organizational pattern found on liver plasma membranes showed that the receptors occurred predominantly as single receptor sites (3) . Cytochalasin B, but not cytochalasin D, was found to partially disrupt the groups of receptors on adipocytes as determined by both visual and computer-assisted analytical methods (2, 4) . These findings indicated that neither microfilaments nor actin is involved in maintaining the grouped receptors and suggested that cytochalasin B, due to its thiol binding properties (5) , may prevent the formation of disulfide bonds that, in part, hold together the groups of insulin receptors.
Recent biochemical studies further documented the involvement of disulfide bonds in insulin receptors. First, a number of investigators, using a variety of tissues, have shown that the subunits of the insulin receptor are held together by disulfide bonds (6, 7) . These data further suggested that at least two classes of interpeptide disulfide bonds are involved in the nonreduced receptor complex (6) . Second, Schweitzer et al. (8) have shown that disruption of disulfide bonds in adipocyte plasma membranes by low concentrations of dithiothreitol markedly increases insulin binding to membranes. Dithiothreitol had little, if any, effect on insulin binding to liver plasma membranes (8) . The findings on liver plasma membranes were confirmed by Jacobs and Cuatrecasas (9) , who also found that dithiothreitol treatment ofplacental membranes decreases insulin binding to these membranes. These biochemical findings, coupled with the different organizational patterns of insulin receptors on adipocyte (1, 2) , liver (3, 10) , and placental (11) membranes suggested that, not only are disulfide bonds involved with the insulin receptors but also, some form of tissue-specific heterogeneity of insulin receptor complexing occurs.
The present study was undertaken to further elucidate the role of disulfide bonds in maintaining the groups of insulin receptors in adipocyte plasma membranes. Dithiothreitol, a potent reducing agent, was found to cause partial disruption ofthe receptor groups similar in magnitude to that caused by cytochalasin B. The dithiothreitol disruption was reversed by oxidized glutathione. N-Ethylmaleimide, a thiol reagent that irreversibly alkylates sulfhydryl groups, also caused partial disruption of the receptor groups, and its effect was slightly additive to the dithiothreitol effect. These data, together with earlier morphological and biochemical data, suggested that two different types of disulfide bonds are involved in maintaining groups ofinsulin receptors on the adipocyte plasma membrane. One type of disulfide linkage was susceptible to both reducing and thiol reagents and was involved in holding the groups of receptors together. The other type of disulfide bond was susceptible to reducing agents only and, on reduction by dithiothreitol, resulted in increased insulin binding to adipocyte membranes. Some of these results have been presented previously. * MATERIALS AND METHODS Male Sprague-Dawley rats weighing 120-140 g were obtained from Harlan Industries (Indianapolis, IN). Collagenase, bovine serum albumin, dithiothreitol, N-ethylmaleimide, and oxidized glutathione were purchased from Sigma. Porcine insulin (lot PJ 5682, 23.1 units/mg) was a gift from R. Chance (Eli Lilly). Ferritin was purchased from Miles. Glutaraldehyde, osmium tetroxide, and other reagents specifically related to electron microscopy were purchased from Polysciences (Warrington, PA). Other reagents and materials were obtained from standard sources.
Adipocytes were isolated from rat epididymal fat pads as described (2) and plasma membranes were prepared as described by McKeel and Jarett (12) . The plasma membrane fraction was suspended in Krebs-Ringer phosphate buffer (pH 7.4), and used immediately. The conjugation ofinsulin to ferritin (13) has recently been modified and described in detail (14) . Monomeric ferritin-insulin was subjected to extensive analysis to document its insulin-like properties and its validity as an ultrastructural
The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. marker for occupied insulin receptors. Ferritin-insulin was found to have full biological activity as compared with native insulin in a glucose oxidation assay based on the concentration of immunologically reactive insulin in the conjugate as determined by radioimmunoassay (14) . In addition, these results proved that monomeric ferritin-insulin specifically bound to the insulin receptor with the same apparent affinity as '25I-labeled insulin, was displaced by unlabeled insulin, was stable under a variety of storage and incubation conditions, and contained no unlabeled insulin (14) . It has also been shown that monomeric ferritin-insulin prevented degradation of '25I-labeled insulin by adipocytes identically to unlabeled insulin (unpublished data). Finally, the calculated number of occupied insulin receptors per pum2 of cell surface using comparable concentrations of "I or ferritin-labeled insulin was approximately the same (16, 17) .
Freshly prepared adipocyte plasma membranes were divided into equal portions and treated with reducing, alkylating, and oxidizing agents either individually or by sequential incubation for 10 min at 370C as described (8) . Between incubations, the membranes were pelleted by centrifugation at 10,000 X g for 20 min at 40C, the supernatants were removed by aspiration, and the membranes were suspended in fresh Krebs-Ringer phosphate buffer (pH 7.4) for further incubation or use in the binding assay. Incubations with monomeric ferritin-insulin were carried out in a total volume of 0.5 ml with 3.5 nM monomeric ferritin-insulin. Nonspecific binding of monomeric ferritin-insulin was assessed by incubating membranes with it in the presence of 4 tkM unlabeled insulin or by substituting unlabeled ferritin for monomeric ferritin-insulin at the same ferritin concentration. As previously reported (14) , excess unlabeled insulin prevented binding of monomeric ferritin-insulin to membranes and unlabeled ferritin did not bind to membranes. All binding assays were carried out at 240C and were terminated after 20 min by diluting the reaction mixture (0.5 ml) with 2 ml of Krebs-Ringer phosphate buffer (pH 7.4) at 0-4°C. The membranes were pelleted by centrifugation at 10,000 X g for 20 min at 4°C and the supernatants were removed by aspiration. The membrane pellets were prepared for electron microscopic analysis as described (13) .
The experiments were analyzed on coded high-magnification (x 150,000) micrographs of randomly selected areas of the sectioned plasma membrane pellet. The analysis ofthe distribution pattern of the insulin receptors and the classification of the receptor sites into groups of two to six molecules per group was based on our previous finding that the maximum distance between nearest neighbors in a group is approximately 400 A (4). Monomeric ferritin-insulin particles with interparticle distances of400 A or less were considered grouped. Each experiment was carried out two to five times and 1,500-2,000 receptor sites were observed and classified for each experimental condition. Statistical dent disruption of the monomeric ferritin-insulin receptor groups (Fig. 1) . The number of insulin receptors present as groups ofthree or more decreased to <20% ofthe total number of receptors when the plasma membranes were treated with 1.0 mM dithiothreitol. The decrease in groups of three through six receptor sites was significant (P < 0.01 for groups of three and P < 0.001 for groups offour, five, and six). This decrease from the control value occurred concomitantly with increases in the numbers ofreceptors found as pairs oras single molecules. After treatment with dithiothreitol, the number of single receptors increased from 35% in the control to >50%. The increase in single receptor molecules caused by both 0.5 and 1 mM dithiothreitol was highly significant (P < 0.001) compared with control values. The increase in groups oftwo receptors was also significant at 0.5 and 1.0 mM dithiothreitol (P < 0.025 and 0.01, respectively). The smaller change in the groups oftwo receptors can be explained as in our previous studies (2) . The (Fig. 2B) . As compared with the receptor distribution after dithiothreitol treatment (Fig. 1) 50% ofthe total while decreasing the number ofgroups ofthree to six receptors. N-Ethylmaleimide caused a disruption similar to that observed with dithiothreitol. Sequential incubation with dithiothreitol followed by N-ethylmaleimide showed that the N-ethylmaleimide effect was slightly (P < 0.025) additive with the dithiothreitol redistribution. The additive effect of these two agents resulted either from disruption of distinct disulfide bonds within the receptor groups or by N-ethylmaleimide alkylation of the free sulfhydryl groups generated by dithiothreitol reduction of disulfide bonds and the consequent prevention of spontaneous reoxidation during subsequent incubation. Comparison Previous studies from this laboratory suggested that changes involving disulfide bonds were at least part of the mechanism involved in maintaining the insulin receptor groups. This conclusion was based on several observations. Cytochalasin B, but not cytochalasin D, partially disrupted the groups of insulin receptors (2, 4) . These findings, coupled with the observations that both cytochalasin B and D effectively disrupt microfilaments and actin (18) but only cytochalasin B appears to bind to thiol groups (5) , suggested that microfilaments were not involved. The biochemical finding that dithiothreitol markedly increased insulin binding to adipocyte plasma membranes (8) further supported the concept of the involvement of disulfide bonds in the insulin receptor groups because dithiothreitol had no effect on insulin binding to liver membranes (8, 9) , which contain substantially fewer groups of insulin receptors than the adipocyte (3). We have shown that dithiothreitol, at concentrations that markedly increased insulin binding to the adipocyte (8, 9) , and placenta (9) and the variations in the ultrastructural organization of the receptor in those tissues (1, 3, 11) .
The differences in-the effects ofdithiothreitol, N-ethylmaleimide, and cytochalasin B on insulin binding and on the disruption ofgroups ofin-sulin receptors on adipocyte plasma membranes suggested that these agents are affecting two functionally different sets ofdisulfide bonds. A proposed model is illustrated in Fig. 4 . One set of disulfide bonds appears to be relatively unstable, spontaneously undergoing reduction to sulfhydryl groups and reoxidation to the disulfide state, with the disulfide bond favored at equilibrium. All three reagents tested would decrease the number of disulfide bonds either by direct disruption (dithiothreitol) or by shifting the equilibrium through alkylation (N-ethylmaleimide) of or reversible binding (cytochalasin B) to the sulfhydryl groups. Therefore, we speculate that these unstable disulfide bonds are involved in maintaining the grouped arrangement of the insulin receptor. The effect of dithiothreitol could be reversed by oxidized glutathione, the effect of cytochalasin B could be reversed by removal of cytochalasin B from the cell, but the effect of N-ethylmaleimide would not be reversible because of the permanent nature of alkylation. The additive effects of N-ethylmaleimide and dithiothreitol may be a result ofalkylation ofthe sulfhydryl groups and consequent prevention of the normal spontaneous reoxidation to the disulfide state that follows the removal of dithiothreitol from the incubation medium. From our previous data, it was clear that, once the disulfide bond has been disrupted, N-ethylmaleimide can alkylate the sulfhydryl groups and prevent oxidized glutathione from reversing the dithiothreitol effect (8) .
The second type of disulfide bond would be more stable and not susceptible to significant spontaneous reduction. These disulfide bonds are involved in the effect of dithiothreitol on insulin binding and the reversal caused by oxidized glutathione. N-Ethylmaleimide and cytochalasin B would have little, if any, effect on these bonds because of the lack of spontaneous reduction and availability of sulfhydryl groups.
It is not clear where these two sets of disuffide bonds are located. It is possible that the unstable bonds are between neighboring protein molecules in the plasma membrane itself, surrounding the insulin receptor and helping to hold it together in the aggregated state. The morphological observations imply that these bonds have some tissue specificity because of the variations in insulin receptor aggregation found in different tissues (1, 3, 11) . The stable disulfide bonds that are affected only by dithiothreitol may be the type I disulfide bond suggested by Czech et al. (6) to hold the two identical halves of the insulin receptor together. Massague and Czech (19) have found that lower concentrations ofdithiothreitol disrupt the insulin receptor into two identical pairs containing both a and (3 subunits. Other data concerning the insulin receptor suggest that it is bivalent (7, 20 Proc. Natl. Acad. Sci. USA 80 (1983) Proc. Natl Acad. Sci. USA 80 (1983) 1027 affinity of the low-affinity sites was markedly increased without changing the total number of receptors.
Considerable morphological and biochemical data exist showing heterogeneity in the organizational structure ofthe insulin receptor from tissue to tissue (1, 3, 11) and even heterogeneity of the receptor in the same tissue (21) (22) (23) (24) . Recently, Linsley and Fox (25) have shown biochemically that the receptor for epidermal growth factor in the membrane of A-431 human epidermal and carcinoma cells occurs in heterogeneous aggregated states. It is tempting to speculate that a relationship exists between the differences in insulin receptor organization, the response to disulfide or thiol reagents, and the physiological responses ofvarious tissues to insulin. However, critical analysis at this time will not allow such a conclusion. For example, it seems feasible that the naturally occurring groups of insulin receptors on adipocytes may be responsible for the greater sensitivity of that tissue to insulin. In fact, studies have suggested that the grouping of receptors would explain several characteristics of insulin binding to adipocytes. Yet data from our laboratory (2) have shown that cytochalasin B partially disrupted the groups of receptors without altering the insulin responsiveness of the cells or binding of insulin to the cells. The present study showed that dithiothreitol partially disrupted the grouping at concentrations that markedly increased insulin binding to adipocytes yet Massaque and Czech (19) have reported no effect of high concentrations of dithiothreitol on the response of the adipocyte to insulin. Goko et al (26) have reported that low concentrations of dithiothreitol, which disrupt the stable disulfide bond with resulting morphological redistribution and binding changes, caused a dose-dependent stimulation of basal glucose oxidation and inhibition of epinephrine and corticotropin-induced lipolysis. Possibly, alteration of the stable disulfide bond in the insulin receptor can elicit insulin-like responses. We may be forced to conclude that, in some cases, observable ultrastructural differences exist in the organization ofinsulin receptors in the membranes ofvarious tissues that have little, if any, bearing on properties of insulin binding and action. These tissue-specific differences may be more directly related to the general organization and composition of the plasma membrane of the particular tissue rather than to the insulin receptor per se. However, further morphological and biochemical analysis are necessary to understand these tissue differences and the role disulfide bonds play in both the structure and function of the insulin receptor.
